CLINICAL_TRIALS trial_result · 2010-07-13

Clinical Trial Update: Follow-up Study to Evaluate Sustained Clearance Rates of Actinic Keratoses up to One Year

A follow-up study reports on sustained clearance rates of actinic keratoses for up to one year, with results posted for the completed trial.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Graceway Pharmaceuticals, LLC | Conditions: Actinic Keratoses | Status: COMPLETED | Results posted: 2010-07-13